Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yukiya, Oshima"'
Autor:
Hideto, Kameda, Keiichiro, Nishida, Toshihiro, Nanki, Akira, Watanabe, Yukiya, Oshima, Shigeki, Momohara
Publikováno v:
Modern Rheumatology. 33:460-471
Objectives To report 24-week safety and effectiveness of certolizumab pegol (CZP) in Japanese patients with rheumatoid arthritis from a post-marketing surveillance study. Methods Enrolled patients were newly receiving CZP. All adverse events (AEs) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7484ce29187e3f9978460e9ae3b051f0
https://doi.org/10.1093/mr/roac073
https://doi.org/10.1093/mr/roac073
Autor:
Hideto Kameda, Keiichiro Nishida, Toshihiro Nanki, Akira Watanabe, Yukiya Oshima, Shigeki Momohara
Publikováno v:
Modern Rheumatology; May2023, Vol. 33 Issue 3, p460-471, 12p, 1 Diagram, 4 Charts, 3 Graphs
Autor:
Toshihiro Nannki, Akira Watanabe, Keiichiro Nishida, Shigaki Momohara, Hideto Kameda, Yukiya Oshima
Publikováno v:
Japanese Journal of Clinical Immunology. 40:196-205
Objective: To evaluate the safety and effectiveness of certolizumab pegol (CZP) in a real-world setting among Japanese patients with rheumatoid arthritis. Methods Post-marketing surveillance data from 2,579 patients treated with CZP were analyzed. Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eb3b6576c6d421b20126501cd15c9c2
https://doi.org/10.2177/jsci.40.196
https://doi.org/10.2177/jsci.40.196